Breakthrough in cryonics practice: Frozen rabbit brain successfully restored
Release time:
2018-03-28
"Every neuron and process appears to be intact in the brain," said Kenneth Hayworth, president of the Brain Conservation Foundation.
By Brooks Hays | Feb. 10, 2016 at 10:10 AM
February 10, 2016 Source: United Press International Social Science News Network Translator: Mico
Fontana, California, February 10, United Press International reported - A scientific team called "21st Century Medicine" successfully froze a rabbit brain and restored it back at a research institution in California.
This feat recently earned the team the Small Mammal Brain Preservation Award from the Brain Preservation Foundation.
"This is a near-perfect achievement, which shows that it is feasible to preserve the complete structure of mammalian brain organs for a long time." Foundation officials wrote in a press release.
The research team took advantage of a newly invented technology called "aldehyde-stabilized freezing." The process went through: first injecting glutaraldehyde into the brain, then injecting 65% ethylene glycol to stabilize and protect the brain structure, and then freezing the rabbit brain to -211 degrees Fahrenheit.
The difficulty with cryopreservation is that it cannot fully protect and preserve the brain's synaptic circuits, those fragile and critical neural parts that enable memory and learning, and are also key to decoding a person's identity. But recent successes show that the freezing method can work.
"Every neuron and process appears to be intact in the brain," said Kenneth Hayworth, president of the Brain Preservation Foundation. "What's amazing is that when the brain was vitrified and became very strong, the brain I held in my hand was the same as the original body. This is different from previous cryonics."
The same research team used ASC (cryopreservation technology stabilized with acetaldehyde) on pig brains that are structurally larger and closer to the human brain, and are currently awaiting experimental results.
The team's success with rabbit brains is detailed in a new research paper published in Cryobiology.
Latest developments
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
According to the latest announcement from the International Society of Cryobiology, Professor Xu Yi from the School of Health Science and Engineering at the University of Shanghai for Science and Technology, and a member of the Yinfeng Cryomedicine Expert Committee, has been elected as a Board Governor of the Society for a three-year term (2026–2028). The election was conducted through a democratic vote by all members worldwide, with three new Board Governors elected. Professor Xu Yi is the only scholar from Asia elected to the Society’s Board of Governors this time and the third elected scholar from mainland China in the Society’s 60-year history.